Screener / SEC EDGAR /CIK 0001420800 /10-K filed Feb 26, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Medical Devices

Enovis CORP ENOV

Compare with peers Embed

ENOV among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
+6.7%102nd of 155 · median +10.5%
Net margin
-4.1%15.3%
-22.9%128th of 154 · median 6.8%
Return on equity
-5.2%18.5%
-35.3%127th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
3.0%105th of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
0.8469th of 108 · median 0.69

ENOV and 9 peers, year by year

The 9 Health care companies closest to ENOV in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
ENOV Enovis CORP FY2025 $2.2B+6.7%59.8%−50.0%−52.7%0.9%−79.5%0.87
CON Concentra Group Holdings Parent, Inc. FY2025 $2.2B+13.9%-15.4%7.7%9.1%42.3%4.00
TFX Teleflex Inc FY2025 $2.0B+17.2%56.2%5.9%−45.4%0.1%−29.0%0.85
RDNT RadNet, Inc. FY2025 $2.0B+11.5%-3.0%−0.9%-−1.7%1.00
ICUI ICU Medical Inc FY2025 $2.2B−6.3%36.8%1.9%0.0%4.1%0.0%0.60
PRVA Privia Health Group, Inc. FY2025 $2.1B+22.3%-1.6%1.1%-3.1%-
EXEL Exelixis, Inc. FY2025 $2.3B+7.0%-37.6%33.7%37.7%36.2%-
MRNA Moderna FY2025 $1.9B−39.9%-−158.1%−145.2%−106.2%−32.6%0.07
QDEL QuidelOrtho Corp FY2025 $2.7B−1.9%-−33.7%−41.5%−3.0%−58.9%1.40
MSA MSA Safety Inc FY2025 $1.9B+3.7%46.5%19.8%14.9%15.8%20.4%0.42

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL

ENOVEnovis CORP
FY2016 revenue $3.2BFY2017 revenue $3.3BFY2018 revenue $3.7BFY2019 revenue $3.3BFY2020 revenue $1.1BFY2021 revenue $1.4BFY2022 revenue $1.6BFY2023 revenue $1.7BFY2024 revenue $2.1BFY2025 revenue $2.2B FY2016 net margin 4.0%FY2017 net margin 4.6%FY2018 net margin 3.8%FY2019 net margin −15.9%FY2020 net margin 3.8%FY2021 net margin 5.0%FY2022 net margin −0.9%FY2023 net margin −1.9%FY2024 net margin −39.2%FY2025 net margin −52.7% FY2016FY2025
Revenue$2.2B Growth+6.7% Net margin−52.7%
CONConcentra Group Holdings Parent, Inc.
FY2022 revenue $1.7BFY2023 revenue $1.8BFY2024 revenue $1.9BFY2025 revenue $2.2B FY2022 net margin 9.7%FY2023 net margin 9.8%FY2024 net margin 8.8%FY2025 net margin 7.7% FY2016FY2025
Revenue$2.2B Growth+13.9% Net margin7.7%
TFXTeleflex Inc
FY2016 revenue $1.9BFY2017 revenue $2.1BFY2018 revenue $2.4BFY2019 revenue $2.6BFY2020 revenue $2.5BFY2021 revenue $2.8BFY2022 revenue $2.8BFY2023 revenue $1.7BFY2024 revenue $1.7BFY2025 revenue $2.0B FY2016 net margin 12.7%FY2017 net margin 7.1%FY2018 net margin 8.2%FY2019 net margin 17.8%FY2020 net margin 13.2%FY2021 net margin 17.3%FY2022 net margin 13.0%FY2023 net margin 20.8%FY2024 net margin 4.1%FY2025 net margin −45.4% FY2016FY2025
Revenue$2.0B Growth+17.2% Net margin−45.4%
RDNTRadNet, Inc.
FY2016 revenue $884.5MFY2017 revenue $922.2MFY2018 revenue $975.1MFY2019 revenue $1.2BFY2020 revenue $1.1BFY2021 revenue $1.3BFY2022 revenue $1.4BFY2023 revenue $1.6BFY2024 revenue $1.8BFY2025 revenue $2.0B FY2016 net margin 0.8%FY2017 net margin 0.0%FY2018 net margin 3.3%FY2019 net margin 1.3%FY2020 net margin −1.4%FY2021 net margin 1.9%FY2022 net margin 0.7%FY2023 net margin 0.2%FY2024 net margin 0.2%FY2025 net margin −0.9% FY2016FY2025
Revenue$2.0B Growth+11.5% Net margin−0.9%
ICUIICU Medical Inc
FY2016 revenue $379.4MFY2017 revenue $1.3BFY2018 revenue $1.4BFY2019 revenue $1.3BFY2020 revenue $1.3BFY2021 revenue $1.3BFY2022 revenue $2.3BFY2023 revenue $2.3BFY2024 revenue $2.4BFY2025 revenue $2.2B FY2016 net margin 16.6%FY2017 net margin 5.3%FY2018 net margin 2.1%FY2019 net margin 8.0%FY2020 net margin 6.8%FY2021 net margin 7.8%FY2022 net margin −3.3%FY2023 net margin −1.3%FY2024 net margin −4.9%FY2025 net margin 0.0% FY2016FY2025
Revenue$2.2B Growth−6.3% Net margin0.0%
PRVAPrivia Health Group, Inc.
FY2019 revenue $786.4MFY2020 revenue $817.1MFY2021 revenue $966.2MFY2022 revenue $1.4BFY2023 revenue $1.7BFY2024 revenue $1.7BFY2025 revenue $2.1B FY2019 net margin 1.0%FY2020 net margin 3.8%FY2021 net margin −19.5%FY2022 net margin −0.6%FY2023 net margin 1.4%FY2024 net margin 0.8%FY2025 net margin 1.1% FY2016FY2025
Revenue$2.1B Growth+22.3% Net margin1.1%
EXELExelixis, Inc.
FY2016 revenue $191.5MFY2017 revenue $452.5MFY2018 revenue $853.8MFY2019 revenue $967.8MFY2020 revenue $987.5MFY2021 revenue $1.4BFY2022 revenue $1.6BFY2023 revenue $1.8BFY2024 revenue $2.2BFY2025 revenue $2.3B FY2016 net margin −36.7%FY2017 net margin 34.1%FY2018 net margin 80.8%FY2019 net margin 33.2%FY2020 net margin 11.3%FY2021 net margin 16.1%FY2022 net margin 11.3%FY2023 net margin 11.4%FY2024 net margin 24.0%FY2025 net margin 33.7% FY2016FY2025
Revenue$2.3B Growth+7.0% Net margin33.7%
MRNAModerna
FY2016 revenue $108.4MFY2017 revenue $205.8MFY2018 revenue $135.1MFY2019 revenue $60.2MFY2020 revenue $803.0MFY2021 revenue $18.5BFY2022 revenue $19.3BFY2023 revenue $6.8BFY2024 revenue $3.2BFY2025 revenue $1.9B FY2016 net margin −199.5%FY2017 net margin −124.3%FY2018 net margin −284.8%FY2019 net margin −853.7%FY2020 net margin −93.0%FY2021 net margin 66.1%FY2022 net margin 43.4%FY2023 net margin −68.8%FY2024 net margin −110.0%FY2025 net margin −145.2% FY2016FY2025
Revenue$1.9B Growth−39.9% Net margin−145.2%
QDELQuidelOrtho Corp
FY2020 revenue $1.7BFY2021 revenue $1.7BFY2022 revenue $3.3BFY2023 revenue $3.0BFY2024 revenue $2.8BFY2025 revenue $2.7B FY2020 net margin 48.8%FY2021 net margin 41.5%FY2022 net margin 16.8%FY2023 net margin −0.3%FY2024 net margin −73.7%FY2025 net margin −41.5% FY2016FY2025
Revenue$2.7B Growth−1.9% Net margin−41.5%
MSAMSA Safety Inc
FY2016 revenue $1.1BFY2017 revenue $1.2BFY2018 revenue $1.4BFY2019 revenue $1.4BFY2020 revenue $1.3BFY2021 revenue $1.4BFY2022 revenue $1.5BFY2023 revenue $1.8BFY2024 revenue $1.8BFY2025 revenue $1.9B FY2016 net margin 8.0%FY2017 net margin 2.2%FY2018 net margin 9.1%FY2019 net margin 9.8%FY2020 net margin 9.2%FY2021 net margin 1.5%FY2022 net margin 11.8%FY2023 net margin 3.3%FY2024 net margin 15.8%FY2025 net margin 14.9% FY2016FY2025
Revenue$1.9B Growth+3.7% Net margin14.9%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

100 500 2000 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, $1.7B, $1.8B, $1.9B, $2.2B CON TFX: $1.9B, $2.1B, $2.4B, $2.6B, $2.5B, $2.8B, $2.8B, $1.7B, $1.7B, $2.0B TFX RDNT: $884.5M, $922.2M, $975.1M, $1.2B, $1.1B, $1.3B, $1.4B, $1.6B, $1.8B, $2.0B RDNT ICUI: $379.4M, $1.3B, $1.4B, $1.3B, $1.3B, $1.3B, $2.3B, $2.3B, $2.4B, $2.2B ICUI PRVA: -, -, -, $786.4M, $817.1M, $966.2M, $1.4B, $1.7B, $1.7B, $2.1B PRVA EXEL: $191.5M, $452.5M, $853.8M, $967.8M, $987.5M, $1.4B, $1.6B, $1.8B, $2.2B, $2.3B EXEL MRNA: $108.4M, $205.8M, $135.1M, $60.2M, $803.0M, $18.5B, $19.3B, $6.8B, $3.2B, $1.9B MRNA QDEL: -, -, -, -, $1.7B, $1.7B, $3.3B, $3.0B, $2.8B, $2.7B QDEL MSA: $1.1B, $1.2B, $1.4B, $1.4B, $1.3B, $1.4B, $1.5B, $1.8B, $1.8B, $1.9B MSA ENOV: $3.2B, $3.3B, $3.7B, $3.3B, $1.1B, $1.4B, $1.6B, $1.7B, $2.1B, $2.2B ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, QDEL have no earlier 10-K here. ENOV, TFX: the line is cut where a later 10-K restates the year before (a spin-off or a merger), so the two years are not the same company.

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

−64.4% +241% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, -, +6.6%, +3.4%, +13.9% CON TFX: +3.2%, +14.9%, +14.1%, +6.0%, −2.2%, +10.7%, −0.7%, +6.6%, −0.8%, +17.2% TFX RDNT: +9.3%, +4.3%, +5.7%, +18.4%, −7.1%, +22.7%, +8.7%, +13.0%, +13.2%, +11.5% RDNT ICUI: +11.0%, +241%, +8.3%, −9.6%, +0.4%, +3.6%, +73.2%, −0.9%, +5.4%, −6.3% ICUI PRVA: -, -, -, -, +3.9%, +18.3%, +40.4%, +22.2%, +4.7%, +22.3% PRVA EXEL: -, +136%, +88.7%, +13.3%, +2.0%, +45.3%, +12.3%, +13.6%, +18.5%, +7.0% EXEL MRNA: -, +89.9%, −34.4%, −55.4%, n/m, n/m, +4.3%, −64.4%, −52.7%, −39.9% MRNA QDEL: -, -, -, -, -, +2.2%, +92.3%, −8.2%, −7.2%, −1.9% QDEL MSA: +1.7%, +4.1%, +13.5%, +3.2%, −3.8%, +3.9%, +9.1%, +17.0%, +1.1%, +3.7% MSA ENOV: −7.2%, +3.6%, +13.2%, +51.7%, −7.7%, +27.3%, +9.6%, +9.2%, +23.5%, +6.7% ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −64.4% to +241%. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, EXEL, MRNA, QDEL have no earlier 10-K here.

Gross margin, FY2016 to FY2025

Gross profit / revenue.

19.9% 61.0% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 TFX: 53.3%, 54.6%, 53.2%, 54.3%, 52.2%, 55.2%, 54.9%, 60.7%, 61.0%, 56.2% TFX ICUI: 53.1%, 33.0%, 40.7%, 37.3%, 36.3%, 37.3%, 30.6%, 32.8%, 34.6%, 36.8% ICUI MSA: 45.4%, 45.0%, 45.1%, 45.6%, 44.2%, 43.9%, 44.1%, 47.7%, 47.6%, 46.5% MSA ENOV: 31.2%, 20.3%, 19.9%, 42.1%, 53.9%, 54.5%, 55.6%, 58.0%, 56.0%, 59.8% ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 19.9% to 61.0%. A gap is a year with no number.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
ENOV Dec 31.2%20.3%19.9%42.1%53.9%54.5%55.6%58.0%56.0%59.8%
CON Dec ----------
TFX Dec 53.3%54.6%53.2%54.3%52.2%55.2%54.9%60.7%61.0%56.2%
RDNT Dec ----------
ICUI Dec 53.1%33.0%40.7%37.3%36.3%37.3%30.6%32.8%34.6%36.8%
PRVA Dec ----------
EXEL Jan ----------
MRNA Dec ----------
QDEL Dec ----------
MSA Dec 45.4%45.0%45.1%45.6%44.2%43.9%44.1%47.7%47.6%46.5%
Peer median53.1%45.0%45.1%45.6%44.2%43.9%44.1%47.7%47.6%46.5%

Operating margin, FY2016 to FY2025

Operating income / revenue.

−906.8% 72.0% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, 15.0%, 15.6%, 16.0%, 15.4% CON TFX: 17.1%, 17.3%, 13.1%, 16.5%, 16.7%, 22.4%, 17.9%, 15.1%, 6.1%, 5.9% TFX RDNT: 4.4%, 5.4%, 3.2%, 6.1%, 3.3%, 6.3%, 3.2%, 6.1%, 5.7%, 3.0% RDNT ICUI: 21.9%, −1.0%, 2.1%, 8.5%, 7.7%, 9.4%, −1.9%, 1.0%, 1.8%, 1.9% ICUI PRVA: -, -, -, 2.0%, 3.1%, −22.5%, −1.4%, 1.2%, 1.0%, 1.6% PRVA EXEL: −14.7%, 36.7%, 51.4%, 38.2%, 11.1%, 20.0%, 12.5%, 9.3%, 27.9%, 37.6% EXEL MRNA: −206.4%, −130.9%, −306.0%, −906.8%, −95.0%, 72.0%, 48.9%, −61.9%, −121.9%, −158.1% MRNA QDEL: -, -, -, -, 63.8%, 53.3%, 25.8%, 4.6%, −70.5%, −33.7% QDEL MSA: 14.0%, 3.3%, 12.8%, 13.4%, 12.7%, 1.6%, 15.7%, 12.9%, 21.5%, 19.8% MSA ENOV: 7.4%, 4.1%, 4.1%, 6.1%, −5.9%, −4.4%, −4.6%, −3.8%, −36.8%, −50.0% ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −906.8% to 72.0%. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, QDEL have no earlier 10-K here.

Net margin, FY2016 to FY2025

Net income / revenue.

−853.7% 80.8% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, 9.7%, 9.8%, 8.8%, 7.7% CON TFX: 12.7%, 7.1%, 8.2%, 17.8%, 13.2%, 17.3%, 13.0%, 20.8%, 4.1%, −45.4% TFX RDNT: 0.8%, 0.0%, 3.3%, 1.3%, −1.4%, 1.9%, 0.7%, 0.2%, 0.2%, −0.9% RDNT ICUI: 16.6%, 5.3%, 2.1%, 8.0%, 6.8%, 7.8%, −3.3%, −1.3%, −4.9%, 0.0% ICUI PRVA: -, -, -, 1.0%, 3.8%, −19.5%, −0.6%, 1.4%, 0.8%, 1.1% PRVA EXEL: −36.7%, 34.1%, 80.8%, 33.2%, 11.3%, 16.1%, 11.3%, 11.4%, 24.0%, 33.7% EXEL MRNA: −199.5%, −124.3%, −284.8%, −853.7%, −93.0%, 66.1%, 43.4%, −68.8%, −110.0%, −145.2% MRNA QDEL: -, -, -, -, 48.8%, 41.5%, 16.8%, −0.3%, −73.7%, −41.5% QDEL MSA: 8.0%, 2.2%, 9.1%, 9.8%, 9.2%, 1.5%, 11.8%, 3.3%, 15.8%, 14.9% MSA ENOV: 4.0%, 4.6%, 3.8%, −15.9%, 3.8%, 5.0%, −0.9%, −1.9%, −39.2%, −52.7% ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −853.7% to 80.8%. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, QDEL have no earlier 10-K here.

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

−$4.1B $13.3B FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, $228.4M, $169.4M, $210.3M, $197.1M CON TFX: $357.5M, $355.4M, $354.3M, $334.4M, $346.4M, $580.5M, $263.6M, $159.7M, $211.4M, $1.4M TFX RDNT: $32.4M, $80.9M, $44.6M, $30.2M, -, -, -, -, -, - RDNT ICUI: $66.6M, $79.9M, $67.5M, $4.6M, $130.7M, $199.0M, −$152.4M, $82.3M, $124.7M, $91.8M ICUI PRVA: -, -, -, $18.6M, $38.5M, $54.5M, $47.1M, $80.7M, -, - PRVA EXEL: $204.6M, $144.5M, $382.4M, $514.1M, $178.6M, $346.6M, $334.9M, $292.9M, $671.5M, $875.8M EXEL MRNA: $33.6M, −$389.9M, −$436.6M, −$491.0M, $2.0B, $13.3B, $4.6B, −$3.8B, −$4.1B, −$2.1B MRNA QDEL: -, -, -, -, $564.8M, $513.1M, $744.4M, $70.9M, −$112.1M, −$83.0M QDEL MSA: $109.4M, $206.6M, $229.9M, $128.4M, $157.7M, $155.3M, $114.9M, $50.1M, $242.2M, $295.4M MSA ENOV: $183.7M, $150.0M, $156.7M, $5.5M, $187.2M, $251.9M, −$161.3M, $12.8M, −$67.2M, $19.9M ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$4.1B to $13.3B. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, QDEL have no earlier 10-K here.

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

−815.5% 244.0% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, 13.2%, 9.2%, 11.1%, 9.1% CON TFX: 19.1%, 16.6%, 14.5%, 12.9%, 13.7%, 20.7%, 9.4%, 9.3%, 12.4%, 0.1% TFX RDNT: 3.7%, 8.8%, 4.6%, 2.6%, -, -, -, -, -, - RDNT ICUI: 17.6%, 6.2%, 4.8%, 0.4%, 10.3%, 15.1%, −6.7%, 3.6%, 5.2%, 4.1% ICUI PRVA: -, -, -, 2.4%, 4.7%, 5.6%, 3.5%, 4.9%, -, - PRVA EXEL: 106.9%, 31.9%, 44.8%, 53.1%, 18.1%, 24.2%, 20.8%, 16.0%, 31.0%, 37.7% EXEL MRNA: 31.0%, −189.4%, −323.3%, −815.5%, 244.0%, 72.2%, 23.8%, −55.9%, −125.3%, −106.2% MRNA QDEL: -, -, -, -, 34.0%, 30.2%, 22.8%, 2.4%, −4.0%, −3.0% QDEL MSA: 9.5%, 17.3%, 16.9%, 9.2%, 11.7%, 11.1%, 7.5%, 2.8%, 13.4%, 15.8% MSA ENOV: 5.8%, 4.5%, 4.3%, 0.2%, 16.7%, 17.7%, −10.3%, 0.7%, −3.2%, 0.9% ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −815.5% to 244.0%. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, QDEL have no earlier 10-K here.

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

−79.5% 86.3% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, 17.0%, 15.5%, 60.4%, 42.3% CON TFX: 11.1%, 6.3%, 7.9%, 15.5%, 10.1%, 12.9%, 9.0%, 8.0%, 1.6%, −29.0% TFX RDNT: 13.9%, 0.1%, 25.4%, 9.7%, −9.0%, 10.8%, 3.2%, 0.5%, 0.3%, −1.7% RDNT ICUI: 9.6%, 5.7%, 2.3%, 7.3%, 5.8%, 6.4%, −3.6%, −1.4%, −6.0%, 0.0% ICUI PRVA: -, -, -, 7.7%, 21.3%, −44.1%, −1.7%, 4.1%, 2.3%, 3.1% PRVA EXEL: −78.6%, 54.1%, 53.6%, 19.0%, 5.9%, 10.5%, 7.3%, 9.2%, 23.2%, 36.2% EXEL MRNA: n/m, n/m, −25.1%, −43.7%, −29.2%, 86.3%, 43.7%, −34.0%, −32.7%, −32.6% MRNA QDEL: -, -, -, -, 60.8%, 36.5%, 11.1%, −0.2%, −68.8%, −58.9% QDEL MSA: 16.5%, 4.4%, 19.6%, 19.0%, 14.8%, 2.6%, 19.4%, 6.1%, 24.9%, 20.4% MSA ENOV: 4.4%, 4.3%, 4.3%, −15.3%, 1.2%, 1.6%, −0.4%, −1.0%, −32.2%, −79.5% ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −79.5% to 86.3%. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, MRNA, QDEL have no earlier 10-K here.

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

0.00 11.78 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, -, 0.00, 5.37, 4.00 CON TFX: 0.48, 0.96, 0.85, 0.64, 0.74, 0.49, 0.43, 0.41, 0.39, 0.85 TFX RDNT: 11.78, 9.35, 5.57, 4.92, 3.94, 3.30, 2.56, 1.32, 1.13, 1.00 RDNT ICUI: 0.00, -, -, -, -, 0.00, 0.79, 0.77, 0.81, 0.60 ICUI PRVA: -, -, -, -, 0.23, 0.08, 0.00, -, -, - PRVA EXEL: 2.12, 0.00, -, -, -, -, -, -, -, - EXEL MRNA: -, -, -, -, -, -, -, -, 0.00, 0.07 MRNA QDEL: -, -, -, -, -, 0.00, 0.54, 0.48, 0.83, 1.40 QDEL MSA: 0.70, 0.79, 0.57, 0.48, 0.37, 0.72, 0.62, 0.62, 0.44, 0.42 MSA ENOV: 0.45, 0.30, 0.37, 0.67, 0.63, 0.45, 0.08, 0.14, 0.52, 0.87 ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 11.78. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, MRNA, QDEL have no earlier 10-K here.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
ENOV Dec 0.450.300.370.670.630.450.080.140.520.87
CON Dec -------0.005.374.00
TFX Dec 0.480.960.850.640.740.490.430.410.390.85
RDNT Dec 11.789.355.574.923.943.302.561.321.131.00
ICUI Dec 0.00----0.000.790.770.810.60
PRVA Dec ----0.230.080.00---
EXEL Jan 2.120.00--------
MRNA Dec --------0.000.07
QDEL Dec -----0.000.540.480.831.40
MSA Dec 0.700.790.570.480.370.720.620.620.440.42
Peer median0.700.880.850.640.550.280.580.550.810.85

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

−$30.54 $28.29 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 CON: -, -, -, -, -, -, $1.60, $1.73, $1.46, $1.30 CON TFX: $4.98, $3.27, $4.29, $9.80, $7.09, $10.23, $7.68, $7.53, $1.48, −$20.25 TFX RDNT: $0.15, $0.00, $0.66, $0.29, −$0.29, $0.46, $0.17, $0.05, $0.04, −$0.25 RDNT ICUI: $3.66, $3.29, $1.33, $4.69, $4.02, $4.74, −$3.11, −$1.23, −$4.83, $0.03 ICUI PRVA: -, -, -, $0.09, $0.33, −$1.83, −$0.08, $0.19, $0.11, $0.18 PRVA EXEL: −$0.28, $0.49, $2.21, $1.02, $0.35, $0.72, $0.56, $0.65, $1.76, $2.78 EXEL MRNA: −$3.79, −$4.18, −$4.95, −$1.55, −$1.96, $28.29, $20.12, −$12.33, −$9.28, −$7.26 MRNA QDEL: -, -, -, -, $18.60, $16.43, $9.56, −$0.15, −$30.54, −$16.69 QDEL MSA: $2.42, $0.67, $3.18, $3.52, $3.15, $0.54, $4.56, $1.48, $7.21, $7.09 MSA ENOV: $3.12, $3.66, $3.48, −$11.67, $0.93, $1.40, −$0.25, −$0.61, −$14.93, −$20.75 ENOV
ENOV is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$30.54 to $28.29. A gap is a year with no number. A ring marks where a line starts: CON, PRVA, QDEL have no earlier 10-K here.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out ENOV and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: ENOV's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ENOV/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.